Vertical integration acquisition aimed at securing strategic enzymes for Wobenzym product formulation
QUEBEC CITY, Aug. 18, 2011 /PRNewswire/ - Atrium Innovations Inc. (TSX: ATB), a globally recognized leader in the development,
manufacturing, and commercialization of innovative, science-based
dietary supplements endorsed by health professionals, today announced
the acquisition of Enzimas S.A., a manufacturer of Trypsin and
Chymotrypsin enzymes based in Lujan, Argentina.
Through this transaction, the Company acquires a manufacturing facility
and process that is approved by various regulatory bodies in countries
where Wobenzym products are sold. This acquisition was aimed at
securing two critical enzymes, which are in relatively short supply
worldwide in the quality required for the formulation of Wobenzym
products. Furthermore, the transaction is supported by an attractive
potential return on investment based on anticipated manufacturing cost
Atrium Innovations Inc. is a globally recognized leader in the
development, manufacturing, and commercialization of innovative,
science-based natural health products endorsed by health professionals.
The Company distributes its extensive portfolio of products mainly in
the healthcare practitioner and health food and specialized store
channels, with a primary focus in North America and Europe. Atrium is
at the forefront of science, innovation and education in the dietary
supplement industry. The Company has over 1,000 employees and operates
seven manufacturing facilities. Additional information is available at www.atrium-innovations.com.
About Enzimas S.A.
Enzimas S.A. is a manufacturer of Trypsin and Chymotrypsin extracted
from bovine and porcine glands. It is the only BfArM (German Federal Institute for Drugs and Medical Devices) accredited supplier of those enzymes and was the exclusive supplier of
Trypsin and Chymotrypsin to Atrium Group. The company has
approximately 50 employees and operates a facility in Lujan, Argentina.
Cautionary Note and Forward-Looking Statements
This press release contains certain forward-looking statements with
respect to the Company. These forward-looking statements, by their
nature, require the Company to make certain assumptions and necessarily
involve known and unknown risks and uncertainties that could cause
actual results to differ materially from those expressed or implied in
these forward-looking statements. Forward-looking statements are not
guarantees of performance. These forward-looking statements, including
financial outlooks, may involve, but are not limited to, comments with
respect to the Company's business or financial objectives, its
strategies or future actions, its targets, expectations for financial
condition or outlook for operations and future contingent payments.
Words such as "may", "will", "would", "could", "expect", "believe",
"plan", "anticipate", "intend", "estimate", "continue", or the negative
or comparable terminology, as well as terms usually used in the future
and the conditional, are intended to identify forward-looking
statements. Information contained in forward-looking statements is
based upon certain material assumptions that were applied in drawing a
conclusion or making a forecast or projection, including management's
perceptions of historical trends, current conditions and expected
future developments, as well as other considerations that are believed
to be appropriate in the circumstances. The Company considers these
assumptions to be reasonable based on information currently available
to it, but cautions the reader that these assumptions regarding future
events, many of which are beyond its control, may ultimately prove to
be incorrect since they are subject to risks and uncertainties that
affect the Company and its business.
For additional information with respect to these and other factors and
assumptions underlying the forward-looking statements made in this
press release, see the Company's quarterly and annual Management
Discussion and Analysis for the fiscal year ended December 31, 2010
filed with the Canadian securities commissions. The forward-looking
information set forth herein reflects the Company's expectations as at
the date of this press release and is subject to change after such
date. The Company disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, other than as required by law.
SOURCE ATRIUM INNOVATIONS INC.